CCA
LLY icon

Cravens & Co Advisors’s Eli Lilly LLY Stock Holding History

Cravens & Co Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
1,507
+3
+0.2% +$3.04K 0.9% 26
2025
Q4 		$1.62M Sell
1,504
-15
-1% -$14.3K 1.06% 24
2025
Q3 		$1.16M Sell
1,519
-15
-1% -$11.2K 0.79% 30
2025
Q2 		$1.2M Buy
+1,534
New +$1.19M 0.89% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cravens & Co Advisors's LLY Position: Q1 2026 in Review

Cravens & Co Advisors increased its Eli Lilly (LLY) stake by 0.2% in Q1 2026, buying an estimated $3.04K and bringing the position to 1,507 shares worth $1.39M. The position accounts for 0.9% of the portfolio, ranked #26.

Cravens & Co Advisors first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.62M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cravens & Co Advisors held 1,507 shares of Eli Lilly worth $1.39M as of Q1 2026.
  • Cravens & Co Advisors bought 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
  • Eli Lilly made up 0.9% of Cravens & Co Advisors's portfolio in Q1 2026, its #26 holding.
  • Cravens & Co Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Cravens & Co Advisors's Eli Lilly position peaked at $1.62M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cravens & Co Advisors's 13F filing for Q1 2026, filed 14 May 2026.